Inflammation: therapeutic targets for diabetic neuropathy. - Wikidata - awgldk - TriplyDB

Inflammation: therapeutic targets for diabetic neuropathy.

Inflammation: therapeutic targets for diabetic neuropathy.

http://www.wikidata.org/entity/Q38132718

about

Mesenchymal stem cells to treat diabetic neuropathy: a long and strenuous way from bench to the clinic PLK2 Plays an Essential Role in High D-Glucose-Induced Apoptosis, ROS Generation and Inflammation in Podocytes.The induction of the transcription factor Nrf2 enhances the antinociceptive effects of delta-opioid receptors in diabetic mice.Systems approach to the study of brain damage in the very preterm newborn.The Association between Serum Cytokines and Damage to Large and Small Nerve Fibers in Diabetic Peripheral Neuropathy Effect of enriching the diet with menhaden oil or daily treatment with resolvin D1 on neuropathy in a mouse model of type 2 diabetes.Oxidative and nitrative stress in neurodegeneration.Association Between Tumor Necrosis Factor-α and Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes: a Meta-Analysis.Vitamin D Insufficiency is Associated with Reduced Parasympathetic Nerve Fiber Function in Type 2 Diabetes.The Inhibitory Effects of Cobalt Protoporphyrin IX and Cannabinoid 2 Receptor Agonists in Type 2 Diabetic Mice.A novel thiazolidinediones ATZD2 rescues memory deficits in a rat model of type 2 diabetes through antioxidant and antiinflammation.Effect of Fish Oil vs. Resolvin D1, E1, Methyl Esters of Resolvins D1 or D2 on Diabetic Peripheral Neuropathy.Transcriptional networks of progressive diabetic peripheral neuropathy in the db/db mouse model of type 2 diabetes: An inflammatory story.

P2860

Q26739745-585E949E-8ADA-4FCE-A956-228E3657DA6B Q33842977-9A26EFC9-6C11-46C7-AB44-A68160D53F6B Q33897876-835E9218-C8F0-4C3A-BDE2-EBD5487959EC Q35407486-DBACEE0F-D281-449E-BC10-CC12D2DA59BB Q35557529-03DFEF6C-37BC-4B8C-B906-6A634DC707DF Q35867508-69C16151-6D5E-4651-AFAE-F74A53294ADF Q36326881-004C4C51-9450-4FCC-AC70-67DBA6E96C18 Q38707258-D82B0A5E-3744-429B-BDD4-F2EC31D2DA88 Q42279104-0DC6ED73-8D1A-4342-B5D8-A789771997A0 Q47117348-2CF2FC14-3A8B-4D08-B6CD-4FF75702E81A Q47136653-262FAB0D-69FB-47D2-802A-40B3E1686B27 Q49520691-F2D11690-2320-46DC-8E17-8722E4D44E1A Q52650664-234C50CC-C129-4584-8A22-42E8C8704A83

P2860

Inflammation: therapeutic targets for diabetic neuropathy.

http://www.wikidata.org/entity/Q38132718

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Inflammation: therapeutic targets for diabetic neuropathy.

@en

type

label

Inflammation: therapeutic targets for diabetic neuropathy.

@en

prefLabel

Inflammation: therapeutic targets for diabetic neuropathy.

@en

P1433

Q38132718-7B68BD43-238D-4EBB-8280-1FAFA85E4726

P1476

Q38132718-EABB8723-A50E-4F51-8E0F-F5F87C1BD708

P2093

Q38132718-5B043857-A02F-4541-84F2-60B712755B7C

Q38132718-96EA0CDE-4FA7-4392-89F1-2AD7EEA34CA6

P2860

Q38132718-0BEB2899-8E9E-4B15-8701-F8AAD03721BB

Q38132718-1241CBA2-3F32-4A12-B3AE-EA9BABF5107F

Q38132718-14740BA8-F83B-4D65-A7D2-0BF59B3D18F3

Q38132718-1515D304-8B1A-47FF-A347-27B29515EA73

Q38132718-16E6254E-06D6-4D55-8B33-FE03C3C5CAEC

Q38132718-2003701F-2A4F-4C53-BACF-D37B0FEAF556

Q38132718-2426BD80-66E5-4F83-A32F-60C50C57AA6B

Q38132718-2426C792-9AAF-46BC-B0E0-B87AFDBF6456

Q38132718-2C098B58-05B8-4761-B109-33027B8FD126

Q38132718-2DE7D4B8-5386-494B-A9A4-7374C01E3DBB

P2888

Q38132718-CF56220D-7A53-417D-9D1F-DF1A2CF6C134

P304

Q38132718-A26F098B-A506-4F8C-B65E-09B724EA612A

P31

Q38132718-704720A2-2894-40B6-A2BD-27CA72A9DCCD

P356

Q38132718-0513BFEA-D200-4A1C-B773-F6121ED5D8CE

P433

Q38132718-2FB2396F-2D71-4A4A-864F-150A322B97DA

P478

Q38132718-CDC6DF9D-F029-4E3A-AC3D-20DEBB92D4CF

P577

Q38132718-1B4F3E78-3FF8-4B7F-9C07-DDA501B9926A

P6179

Q38132718-719328B7-28A4-4C94-8EE2-7429166672BB

P698

Q38132718-25A7FA8F-DA5D-421C-99F8-0F48803DFBEA

P921

Q38132718-843339A2-1337-4637-A7E4-A026E959A7EC

P356

S12035-013-8537-0

P1433

Molecular Neurobiology

P1476

Inflammation: therapeutic targets for diabetic neuropathy.

@en

P2093

Jiyin Zhou

http://www.w3.org/2001/XMLSchema#string

Shiwen Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Biochemistry and molecular cell biology of diabetic complications

Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy

Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: a mechanism for the development of chronic sensitization of peripheral nociceptors

Thioredoxin-interacting protein links oxidative stress to inflammasome activation

Type 2 diabetes as an inflammatory disease

Diabetic neuropathy: mechanisms to management

Key role for spinal dorsal horn microglial kinin B1 receptor in early diabetic pain neuropathy.

Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity.

COMP-angiopoietin-1 recovers molecular biomarkers of neuropathy and improves vascularisation in sciatic nerve of ob/ob mice.

P2888

s12035-013-8537-0

P304

536-546

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12035-013-8537-0

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1029998102

http://www.w3.org/2001/XMLSchema#string

P698

23990376

http://www.w3.org/2001/XMLSchema#string

P921